| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.5B | $0.3B | $-0.1B | $0.2B | $0.2B | $-1.6B | $0.3B | $-0.0B |
| EPS (Basic) | $-4.88 | $2.41 | $-1.60 | $2.15 | $0.43 | $0.70 | $0.42 | $-2.31 |
| EPS (Diluted) | $-4.88 | $2.37 | $-1.60 | $2.13 | $0.43 | $0.68 | $0.41 | $-2.31 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.9B | $12.2B | $13.1B | $13.5B | $12.1B | $19.5B | $35.9B | $30.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.8B | $0.5B | $0.7B | $0.7B | $1.2B | $1.4B | $0.6B | $0.4B |
| Total Liabilities | $9.1B | $10.1B | $10.9B | $11.3B | $9.4B | $16.4B | $31.0B | $25.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | — | — | — | — | — | $3.1B | $5.0B | $4.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.2B | $0.3B | $0.6B | $0.4B | $0.6B | $1.1B | $0.7B |
| Investing Cash Flow | $0.9B | $0.9B | $-0.2B | $-2.8B | $6.3B | $14.9B | $-6.1B | $4.8B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.8B | $-1.1B | $-0.5B | $1.2B | $-7.3B | $-14.5B | $5.5B | $-5.5B |